Laboratorio Reig Jofre, S.A. (FRA:FEQ1)

Market Cap	211.76M -13.9%
Revenue (ttm)	337.73M +0.3%
Net Income	6.94M +8.7%
EPS	n/a
Shares Out	n/a
PE Ratio	30.53
Forward PE	12.68
Dividend	0.02 (0.77%)
Ex-Dividend Date	May 21, 2026

Volume	39
Open	2.550
Previous Close	2.530
Day's Range	2.530 - 2.550
52-Week Range	2.130 - 2.960
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the For...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,512
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FEQ1

Financial Performance

In 2025, Laboratorio Reig Jofre's revenue was 336.68 million, a decrease of -1.37% compared to the previous year's 341.37 million. Earnings were 5.02 million, a decrease of -51.64%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error